Guo et al. found that FUT6 was capable in promoting hepatocellular cell growth in vivo and in vitro, by modulating P13K, and also suggesting FUT6 as a promising biomarker and a potential therapeutic target for hepatocellular carcinoma (322). This evidence concerns the gene FUT6 and hepatocellular carcinoma.